In this issue of Rheumatic Disease Clinics, guest editors Drs. Julie J. Paik and Tahseen Mozaffar bring their considerable expertise to the topic of Myositis. Top experts explore key topics, including autoantibodies in myositis: can they predict disease course?; classification criteria in idiopathic inflammatory myopathies: is it time for an update?; diagnostic evaluation for myositis and their pitfalls; updated diagnostic criteria in IBM; and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xiv 7. Foreword - p. xv 8. Preface - p. xvii 9. Autoantibodies in Myositis: Can They Predict Disease Course? - p. 545 10. Classification Criteria in Idiopathic Inflammatory Myopathies: Is It Time for an Update? - p. 563 11. Diagnostic Evaluation for Myositis and Their Pitfalls - p. 577 12. Updates on Diagnostic Criteria of Inclusion Body Myositis - p. 595 13. Emerging Treatment Options for Inclusion Body Myositis - p. 609 14. Management of Lung Manifestations in Idiopathic Inflammatory Myopathies - p. 623 15. Patient-Reported Outcomes in Myositis - p. 643 16. Calcinosis in Adult and Juvenile Dermatomyositis: Pathogenesis and Potential Therapeutic Targets - p. 655 17. The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network - p. 675 18. Physical Activity Monitors in Myositis: Bridging the Gap from Bedside to Clinical Trials - p. 703 19. Promising Treatments in Juvenile Dermatomyositis - p. 719 20. Updates in the Management of Immune-Mediated Necrotizing Myopathy - p. 737 21. The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies - p. 761 22. The Mythology of Polymyositis - p. 777
In this issue of Rheumatic Disease Clinics, guest editors Drs. Julie J. Paik and Tahseen Mozaffar bring their considerable expertise to the topic of Myositis. Top experts explore key topics, including autoantibodies in myositis: can they predict disease course?; classification criteria in idiopathic inflammatory myopathies: is it time for an update?; diagnostic evaluation for myositis and their pitfalls; updated diagnostic criteria in IBM; and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xiv 7. Foreword - p. xv 8. Preface - p. xvii 9. Autoantibodies in Myositis: Can They Predict Disease Course? - p. 545 10. Classification Criteria in Idiopathic Inflammatory Myopathies: Is It Time for an Update? - p. 563 11. Diagnostic Evaluation for Myositis and Their Pitfalls - p. 577 12. Updates on Diagnostic Criteria of Inclusion Body Myositis - p. 595 13. Emerging Treatment Options for Inclusion Body Myositis - p. 609 14. Management of Lung Manifestations in Idiopathic Inflammatory Myopathies - p. 623 15. Patient-Reported Outcomes in Myositis - p. 643 16. Calcinosis in Adult and Juvenile Dermatomyositis: Pathogenesis and Potential Therapeutic Targets - p. 655 17. The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network - p. 675 18. Physical Activity Monitors in Myositis: Bridging the Gap from Bedside to Clinical Trials - p. 703 19. Promising Treatments in Juvenile Dermatomyositis - p. 719 20. Updates in the Management of Immune-Mediated Necrotizing Myopathy - p. 737 21. The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies - p. 761 22. The Mythology of Polymyositis - p. 777
